Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matias Iglicki

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Eye (London, England)|January 19, 2022
Vitrectomized vs non-vitrectomized eyes in DEX implant treatment for DMO-Is there any difference? the VITDEX studyMatias Iglicki, Catharina Busch, Paolo Lanzetta, et al.
International Ophthalmology|July 3, 2020
Current role of intravitreal injections in Irvine Gass syndrome-CRIIG studyAshish Sharma, Francesco Bandello, Anat Loewenstein, et al.
Ophthalmology. Retina|February 4, 2021
Detection of Diabetic Retinopathy from Ultra-Widefield Scanning Laser Ophthalmoscope Images: A Multicenter Deep Learning AnalysisFangyao Tang, Phoomraphee Luenam, An Ran Ran, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|March 20, 2019
Causative Pathogens of Endophthalmitis after Intravitreal Anti-VEGF Injection: An International Multicenter StudyCatharina Busch, Matias Iglicki, Mali Okada, et al.
Eye (London, England)|October 15, 2020
Subclinical subretinal fluid detectable only by optical coherence tomography in choroidal naevi-the SON studyAdrian T Fung, Raymond Guan, Veronica Forlani, et al.
Acta Ophthalmologica|March 3, 2020
Baseline predictors for visual acuity loss during observation in diabetic macular oedema with good baseline visual acuityCatharina Busch, Mali Okada, Dinah Zur, et al.
Acta Diabetologica|May 7, 2018
Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edemaCatharina Busch, Dinah Zur, Samantha Fraser-Bell, et al.
The British Journal of Ophthalmology|August 12, 2019
One-year outcomes of anti-vascular endothelial growth factor therapy in peripapillary choroidal neovascularisationSumit Randhir Singh, Adrian T Fung, Samantha Fraser-Bell, et al.
Acta Diabetologica|March 24, 2019
Real-world outcomes of observation and treatment in diabetic macular edema with very good visual acuity: the OBTAIN studyCatharina Busch, Samantha Fraser-Bell, Dinah Zur, et al.
The British Journal of Ophthalmology|June 13, 2018
Long-term visual outcome and its predictors in macular oedema secondary to retinal vein occlusion treated with dexamethasone implantCatharina Busch, Matus Rehak, Chintan Sarvariya, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Eye (London, England)|January 19, 2022
Vitrectomized vs non-vitrectomized eyes in DEX implant treatment for DMO-Is there any difference? the VITDEX studyMatias Iglicki, Catharina Busch, Paolo Lanzetta, et al.
International Ophthalmology|July 3, 2020
Current role of intravitreal injections in Irvine Gass syndrome-CRIIG studyAshish Sharma, Francesco Bandello, Anat Loewenstein, et al.
Ophthalmology. Retina|February 4, 2021
Detection of Diabetic Retinopathy from Ultra-Widefield Scanning Laser Ophthalmoscope Images: A Multicenter Deep Learning AnalysisFangyao Tang, Phoomraphee Luenam, An Ran Ran, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|March 20, 2019
Causative Pathogens of Endophthalmitis after Intravitreal Anti-VEGF Injection: An International Multicenter StudyCatharina Busch, Matias Iglicki, Mali Okada, et al.
Eye (London, England)|October 15, 2020
Subclinical subretinal fluid detectable only by optical coherence tomography in choroidal naevi-the SON studyAdrian T Fung, Raymond Guan, Veronica Forlani, et al.
Acta Ophthalmologica|March 3, 2020
Baseline predictors for visual acuity loss during observation in diabetic macular oedema with good baseline visual acuityCatharina Busch, Mali Okada, Dinah Zur, et al.
Acta Diabetologica|May 7, 2018
Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edemaCatharina Busch, Dinah Zur, Samantha Fraser-Bell, et al.
The British Journal of Ophthalmology|August 12, 2019
One-year outcomes of anti-vascular endothelial growth factor therapy in peripapillary choroidal neovascularisationSumit Randhir Singh, Adrian T Fung, Samantha Fraser-Bell, et al.
Acta Diabetologica|March 24, 2019
Real-world outcomes of observation and treatment in diabetic macular edema with very good visual acuity: the OBTAIN studyCatharina Busch, Samantha Fraser-Bell, Dinah Zur, et al.
The British Journal of Ophthalmology|June 13, 2018
Long-term visual outcome and its predictors in macular oedema secondary to retinal vein occlusion treated with dexamethasone implantCatharina Busch, Matus Rehak, Chintan Sarvariya, et al.
Pageof 6